Zealand Pharma A/S Return on Tangible Equity 2018-2022 | ZEAL
Current and historical return on tangible equity values for Zealand Pharma A/S (ZEAL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data |
Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
2022-03-31 |
$-0.16B |
$0.11B |
-97.97% |
2021-12-31 |
$-0.16B |
$0.14B |
-81.61% |
2021-09-30 |
$-0.18B |
$0.18B |
-85.27% |
2021-06-30 |
$-0.18B |
$0.22B |
-81.43% |
2021-03-31 |
$-0.14B |
$0.26B |
-60.98% |
2020-12-31 |
$-0.13B |
$0.18B |
-61.14% |
2020-09-30 |
$-0.10B |
$0.24B |
-46.81% |
2020-06-30 |
$-0.08B |
$0.26B |
-39.28% |
2020-03-31 |
$-0.09B |
$0.18B |
-52.15% |
2019-12-31 |
$-0.09B |
$0.19B |
-48.66% |
2019-09-30 |
$-0.07B |
$0.21B |
-42.35% |
2019-06-30 |
$0.09B |
$0.15B |
50.95% |
2019-03-31 |
$0.09B |
$0.17B |
59.86% |
2018-12-31 |
$0.09B |
$0.18B |
74.34% |
2018-09-30 |
$0.09B |
$0.19B |
92.70% |
2018-06-30 |
$-0.06B |
$0.05B |
-77.63% |
2018-03-31 |
$-0.05B |
$0.07B |
-75.71% |
2017-12-31 |
$-0.04B |
$0.08B |
-68.85% |